PubRank

M H Baumann

Author PubWeight™ 37.63‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse 2001 4.03
2 Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications. Circulation 2000 2.41
3 Relationship between the serotonergic activity and reinforcing effects of a series of amphetamine analogs. J Pharmacol Exp Ther 2005 1.70
4 Monoamine releasers with varying selectivity for dopamine/norepinephrine versus serotonin release as candidate "agonist" medications for cocaine dependence: studies in assays of cocaine discrimination and cocaine self-administration in rhesus monkeys. J Pharmacol Exp Ther 2006 1.50
5 Aminorex, fenfluramine, and chlorphentermine are serotonin transporter substrates. Implications for primary pulmonary hypertension. Circulation 1999 1.42
6 Cyclophosphamide and low-dose prednisone therapy in patients with systemic sclerosis (scleroderma) with interstitial lung disease. J Rheumatol 1993 1.38
7 Tension pneumothorax: diagnostic and therapeutic pitfalls. Crit Care Med 1993 1.25
8 Effects of intrapleural heparin or urokinase on the extent of tetracycline-induced pleural disease. Am J Respir Crit Care Med 1995 1.07
9 Selective suppression of cocaine- versus food-maintained responding by monoamine releasers in rhesus monkeys: benzylpiperazine, (+)phenmetrazine, and 4-benzylpiperidine. J Pharmacol Exp Ther 2009 1.03
10 Neurochemical neutralization of methamphetamine with high-affinity nonselective inhibitors of biogenic amine transporters: a pharmacological strategy for treating stimulant abuse. Synapse 2000 1.01
11 Effects of dopamine and serotonin-releasing agents on methamphetamine discrimination and self-administration in rats. Psychopharmacology (Berl) 1999 1.00
12 Quantitative structure-activity relationship analysis of the pharmacology of para-substituted methcathinone analogues. Br J Pharmacol 2015 0.94
13 Nitric oxide inhibits [3H]dopamine uptake. Brain Res 1994 0.91
14 Steric parameters, molecular modeling and hydropathic interaction analysis of the pharmacology of para-substituted methcathinone analogues. Br J Pharmacol 2015 0.88
15 Amphoterin includes a sequence motif which is homologous to the Alzheimer's beta-amyloid peptide (Abeta), forms amyloid fibrils in vitro, and binds avidly to Abeta. Biochemistry 2001 0.87
16 Phentermine and fenfluramine. Preclinical studies in animal models of cocaine addiction. Ann N Y Acad Sci 1998 0.86
17 Studies of the biogenic amine transporters. IV. Demonstration of a multiplicity of binding sites in rat caudate membranes for the cocaine analog [125I]RTI-55. J Pharmacol Exp Ther 1994 0.86
18 Behavioural and neurochemical characteristics of phentermine and fenfluramine administered separately and as a mixture in rats. Psychopharmacology (Berl) 1997 0.84
19 Raphe serotonin neuron-specific oxytocin receptor knockout reduces aggression without affecting anxiety-like behavior in male mice only. Genes Brain Behav 2015 0.83
20 Identification of a primary metabolite of ibogaine that targets serotonin transporters and elevates serotonin. Life Sci 1995 0.83
21 Lack of evidence for context-dependent cocaine-induced sensitization in humans: preliminary studies. Pharmacol Biochem Behav 1994 0.82
22 Alterations in alcohol consumption, withdrawal seizures, and monoamine transmission in rats treated with phentermine and 5-hydroxy-L-tryptophan. Synapse 2006 0.82
23 Systemically administered cocaine alters stimulus-evoked responses of thalamic somatosensory neurons to perithreshold vibrissae stimulation. Brain Res 1998 0.80
24 Methamphetamine dependence: medication development efforts based on the dual deficit model of stimulant addiction. Ann N Y Acad Sci 2000 0.80
25 Restoration of 3,4-methylenedioxymethamphetamine-induced 5-HT depletion by the administration of L-5-hydroxytryptophan. Neuroscience 2007 0.80
26 Endocrine responses during acute nicotine withdrawal. Pharmacol Biochem Behav 1996 0.80
27 Monoaminergic regulation of neuroendocrine function and its modification by cocaine. Front Neuroendocrinol 1994 0.80
28 Neuroendocrine and neurochemical effects of acute ibogaine administration: a time course evaluation. Brain Res 1996 0.79
29 Discovery of novel peptidic dopamine transporter ligands by screening a positional scanning combinatorial hexapeptide library. Synapse 1999 0.78
30 Studies of the biogenic amine transporters. VI. Characterization of a novel cocaine binding site, identified with [125I]RTI-55, in membranes prepared from whole rat brain minus caudate. J Pharmacol Exp Ther 1995 0.78
31 Inhibition of MAO-A fails to alter cocaine-induced increases in extracellular dopamine and norepinephrine in rat nucleus accumbens. Brain Res Mol Brain Res 2001 0.77
32 Studies of the biogenic amine transporters. III. Demonstration of two binding sites for [3H]GBR12935 and [3H]BTCP in rat caudate membranes. J Pharmacol Exp Ther 1994 0.77
33 Less is more? Chest 2001 0.77
34 Inhibition of tuberoinfundibular dopaminergic neural activity during suckling: involvement of mu and kappa opiate receptor subtypes. J Neuroendocrinol 1996 0.77
35 Autoregulation of dopamine synthesis in subregions of the rat nucleus accumbens. Eur J Pharmacol 2001 0.77
36 Combined phentermine/fenfluramine administration and central serotonin neurons. Synapse 1998 0.75
37 Studies of the biogenic amine transporters. V. Demonstration of two binding sites for the cocaine analog [125I]RTI-55 associated with the 5-HT transporter in rat brain membranes. J Pharmacol Exp Ther 1995 0.75
38 Phentermine pretreatment antagonizes the cocaine-induced rise in mesolimbic dopamine. Neuroreport 1996 0.75